Innovating Works

AGENCIA EFE

Active
OLIGOMED: Oligonucleotides for Medical Applications AGENCIA EFE participó en un H2020: H2020-MSCA-ITN-2020 The use of synthetic oligonucleotides (ONs, short DNA or RNA strands) in the treatment of genetic diseases is a rapidly growing field, and t...
2020-08-13 - 2025-06-30 | financed
EDI: European Data Incubator AGENCIA EFE participó en un H2020: H2020-ICT-2016-2017 Only 2 out of the top 20 companies changing lives and making money out of Big Data are European. Europe is not playing the role it should in...
2017-11-21 - 2021-06-30 | financed
EU-SysFlex: Pan European system with an efficient coordinated use of flexibilities for the integration of a larg... AGENCIA EFE participó en un H2020: H2020-LCE-2016-2017 The overall objective is to ensure an efficient and sufficient level of system services are provided to facilitate meeting world leading lev...
2017-09-19 - 2022-02-28 | financed
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.